Biolife Solutions Inc’s recent filing unveils that its Chief Financial Officer Wichterman Troy unloaded Company’s shares for reported $18743.0 on Apr 09 ’25. In the deal valued at $20.11 per share,932 shares were sold. As a result of this transaction, Wichterman Troy now holds 188,310 shares worth roughly $4.13 million.
Then, Mathew Aby J. sold 569 shares, generating $11,443 in total proceeds. Upon selling the shares at $20.11, the EVP & Chief Scientific Officer now owns 309,007 shares.
Before that, Aebersold Sarah sold 210 shares. Biolife Solutions Inc shares valued at $4,223 were divested by the Chief Human Resources Officer at a price of $20.11 per share. As a result of the transaction, Aebersold Sarah now holds 79,884 shares, worth roughly $1.75 million.
H.C. Wainwright initiated its Biolife Solutions Inc [BLFS] rating to a Buy in a research note published on September 30, 2024; the price target was $29. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Craig Hallum began covering BLFS with “Buy” recommendation on July 11, 2023. Oppenheimer revised its rating on April 25, 2022. It rated BLFS as “an Outperform” which previously was an “a Perform”.
Price Performance Review of BLFS
On Thursday, Biolife Solutions Inc [NASDAQ:BLFS] saw its stock fall -1.57% to $21.91. Over the last five days, the stock has gained 4.38%. Biolife Solutions Inc shares have fallen nearly -15.60% since the year began. Nevertheless, the stocks have risen 36.94% over the past one year. While a 52-week high of $29.55 was reached on 01/30/25, a 52-week low of $14.84 was recorded on 04/09/25. SMA at 50 days reached $24.85, while 200 days put it at $24.75.
Levels Of Support And Resistance For BLFS Stock
The 24-hour chart illustrates a support level at 21.59, which if violated will result in even more drops to 21.26. On the upside, there is a resistance level at 22.42. A further resistance level may holdings at 22.92. The Relative Strength Index (RSI) on the 14-day chart is 43.16, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 57.03%. Stochastics %K at 44.66% indicates the stock is a holding.
How much short interest is there in Biolife Solutions Inc?
A steep rise in short interest was recorded in Biolife Solutions Inc stocks on 2025-03-31, growing by 0.18 million shares to a total of 3.58 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 3.4 million shares. There was a rise of 5.1%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on October 19, 2021 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $61 price target.
